Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Deng, Peng  [Clear All Filters]
Journal Article
Chen J, Zuo Z, Gao Y, Yao X, Guan P, Wang Y, Li Z, Liu Z, Hong JHan, Deng P, et al. Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide. Clin Epigenetics. 2023;15(1):19.
Du Y, Zhao H, Feng N, Zheng D, Khan A, Zhou H, Deng P, Wang Y, Lu X, Jiang W. Alginate Oligosaccharides Alleviate Salt Stress in Rice Seedlings by Regulating Cell Wall Metabolism to Maintain Cell Wall Structure and Improve Lodging Resistance. Plants (Basel). 2024;13(9).
Wang C, Li Y, Jia L, Kim JKoo, Li J, Deng P, Zhang W, Krebsbach PH, Wang C-Y. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell. 2021.
Du Y-W, Liu L, Feng N-J, Zheng D-F, Liu M-L, Zhou H, Deng P, Wang Y-X, Zhao H-M. Combined transcriptomic and metabolomic analysis of alginate oligosaccharides alleviating salt stress in rice seedlings. BMC Plant Biol. 2023;23(1):455.
Deng P, Chen Y, Ji N, Lin Y, Yuan Q, Ye L, Chen Q. Cysteine Dioxygenase Type 1 Promotes Adipogenesis via Interaction with Peroxisome Proliferator-activated Receptor gamma. Biochem Biophys Res Commun. 2015.
Liu Z, Suh JSook, Deng P, Bezouglaia O, Do M, Mirnia M, Cui Z-K, Lee M, Aghaloo T, Wang C-Y, et al. Epigenetic Regulation of NGF-Mediated Osteogenic Differentiation in Human Dental Mesenchymal Stem Cells. Stem Cells. 2022.
Chen J, Hong JHan, Huang Y, Liu S, Yin J, Deng P, Sun Y, Yu Z, Zeng X, Xiao R, et al. EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer. Mol Cancer. 2023;22(1):85.
Yu Y, Deng P, Yu B, Szymanski JM, Aghaloo T, Hong C, Wang C-Y. Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3. Stem Cell Reports. 2018;11(6):1579-1580.
Deng P, Zhou C, Alvarez R, Hong C, Wang C-Y. Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells. Stem Cell Reports. 2019;12(1):180-181.
Deng P, Yuan Q, Cheng Y, Li J, Liu Z, Liu Y, Li Y, Su T, Wang J, Salvo MEkimyan, et al. Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell. 2021.
Deng P, Chang I, Wang J, Badreldin AA, Li X, Yu B, Wang C-Y. Loss of KDM4B impairs osteogenic differentiation of OMSCs and promotes oral bone aging. Int J Oral Sci. 2022;14(1):24.
Yu Z, Deng P, Chen Y, Lin D, Liu S, Hong J, Guan P, Chen J, Zhong M-E, Chen J, et al. Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer. Proc Natl Acad Sci U S A. 2024;121(6):e2304619121.
Wang Y, Zhou W, Chen J, Chen J, Deng P, Chen H, Sun Y, Yu Z, Pang D, Liu L, et al. Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphoma. MedComm (2020). 2023;4(4):e284.
Deng P, Wang Z, Chen J, Liu S, Yao X, Liu S, Liu L, Yu Z, Huang Y, Xiong Z, et al. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. J Clin Invest. 2022.
Liu Z, Yin Y, Wang Z, Xie L, Deng P, Wang D, Ji N, Zhao H, Han X, Chen Q, et al. RANKL inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia. Bone. 2021:116301.
Liu S, Zou Q, Chen J-P, Yao X, Guan P, Liang W, Deng P, Lai X, Yin J, Chen J, et al. Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer. J Clin Invest. 2021.
Lee H-L, Yu B, Deng P, Wang C-Y, Hong C. TGF-β-Induced KDM4B Promotes Chondrogenic Differentiation of Human MSCs. Stem Cells. 2015.